A phase II study of afatinib in patients (pts) with metastatic human epidermal growth factor receptor (HER2)-positive trastuzumab-refractory esophagogastric (EG) cancer Meeting Abstract


Authors: Janjigian, Y. Y.; Capanu, M.; Gromisch, C. M.; Kelsen, D. P.; Ku, G. Y.; Brown, K. T.; Schattner, M.; Ilson, D. H.; Solit, D. B.; Berger, M. F.; Vakiani, E.
Abstract Title: A phase II study of afatinib in patients (pts) with metastatic human epidermal growth factor receptor (HER2)-positive trastuzumab-refractory esophagogastric (EG) cancer
Meeting Title: 49th Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 31
Issue: 15 Suppl.
Meeting Dates: 2013 May 31-Jun 4
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2013-05-20
Language: English
ACCESSION: WOS:000335419603683
PROVIDER: wos
Notes: Meeting Abstract : e15017 -- Source: Wos
MSK Authors
  1. David Solit
    431 Solit
  2. Geoffrey Yuyat Ku
    86 Ku
  3. Marinela Capanu
    206 Capanu
  4. Yelena Yuriy Janjigian
    145 Janjigian
  5. Karen T Brown
    161 Brown
  6. David H Ilson
    269 Ilson
  7. Michael Forman Berger
    380 Berger
  8. Mark Schattner
    102 Schattner
  9. Efsevia Vakiani
    162 Vakiani
  10. David P Kelsen
    332 Kelsen